Molecular Hematopathology

Rong He, Jennifer Oliveira, James Hoyer, David S. Viswanatha

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Molecular and cytogenetic analysis is a critical component of hematopathology practice. Correct diagnostic classification, prognosis and therapeutic decisions are often predicated on the presence or absence of tumor-specific genetic abnormalities. Understanding the wide range of abnormalities associated with hematologic neoplasia and interpreting a large number of molecular diagnostic techniques can pose challenges for hematopathologists. From chromosome translocations to complex RNA or DNA mutation patterns, the application of molecular diagnosis has greatly enriched our definitions of lymphoid and myeloid neoplasms. The incessant pace of new technological advances such as next-generation sequencing, as well as medical and scientific knowledge accumulation, requires the continuous updating of our knowledge to make judicious decisions regarding cost-effective yet comprehensive approaches to molecularly characterize hematologic cancers. This chapter encompasses an overview of the test design considerations, molecular diagnostic techniques, and rational application of these tests to non-Hodgkin lymphoma and myeloid malignancies in modern hematopathology practice. The field of benign hematology is also greatly expanding with the broader use of molecular analysis. Disorders of hemoglobins, erythrocytosis, and hemolysis have underlying constitutional genetic abnormalities enabling the diagnostic application of molecular testing in an increasingly sophisticated manner. These advances will also be summarized in this chapter.

Original languageEnglish (US)
Title of host publicationHematopathology
Subtitle of host publicationA Volume in the Series: Foundations in Diagnostic Pathology
PublisherElsevier Inc.
Pages712-760.e18
ISBN (Electronic)9780323512312
ISBN (Print)9780323479134
DOIs
StatePublished - Dec 1 2017

Fingerprint

Molecular Diagnostic Techniques
Neoplasms
Polycythemia
Cytogenetic Analysis
Hematology
Hemolysis
Non-Hodgkin's Lymphoma
Hemoglobins
Chromosomes
RNA
Costs and Cost Analysis
Mutation
DNA
Therapeutics

Keywords

  • Cytogenetics
  • FISH
  • Minimal residual disease
  • Molecular basis of red cell diseases
  • Molecular diagnosis of lymphoma and myeloid neoplasms
  • Molecular laboratory techniques
  • Next-generation sequencing
  • PCR
  • Real-time PCR
  • Sequencing
  • Translocations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

He, R., Oliveira, J., Hoyer, J., & Viswanatha, D. S. (2017). Molecular Hematopathology. In Hematopathology: A Volume in the Series: Foundations in Diagnostic Pathology (pp. 712-760.e18). Elsevier Inc.. https://doi.org/10.1016/B978-0-323-47913-4.00024-0

Molecular Hematopathology. / He, Rong; Oliveira, Jennifer; Hoyer, James; Viswanatha, David S.

Hematopathology: A Volume in the Series: Foundations in Diagnostic Pathology. Elsevier Inc., 2017. p. 712-760.e18.

Research output: Chapter in Book/Report/Conference proceedingChapter

He, R, Oliveira, J, Hoyer, J & Viswanatha, DS 2017, Molecular Hematopathology. in Hematopathology: A Volume in the Series: Foundations in Diagnostic Pathology. Elsevier Inc., pp. 712-760.e18. https://doi.org/10.1016/B978-0-323-47913-4.00024-0
He R, Oliveira J, Hoyer J, Viswanatha DS. Molecular Hematopathology. In Hematopathology: A Volume in the Series: Foundations in Diagnostic Pathology. Elsevier Inc. 2017. p. 712-760.e18 https://doi.org/10.1016/B978-0-323-47913-4.00024-0
He, Rong ; Oliveira, Jennifer ; Hoyer, James ; Viswanatha, David S. / Molecular Hematopathology. Hematopathology: A Volume in the Series: Foundations in Diagnostic Pathology. Elsevier Inc., 2017. pp. 712-760.e18
@inbook{df2df1e635dd4d36a033442a9d0bd61f,
title = "Molecular Hematopathology",
abstract = "Molecular and cytogenetic analysis is a critical component of hematopathology practice. Correct diagnostic classification, prognosis and therapeutic decisions are often predicated on the presence or absence of tumor-specific genetic abnormalities. Understanding the wide range of abnormalities associated with hematologic neoplasia and interpreting a large number of molecular diagnostic techniques can pose challenges for hematopathologists. From chromosome translocations to complex RNA or DNA mutation patterns, the application of molecular diagnosis has greatly enriched our definitions of lymphoid and myeloid neoplasms. The incessant pace of new technological advances such as next-generation sequencing, as well as medical and scientific knowledge accumulation, requires the continuous updating of our knowledge to make judicious decisions regarding cost-effective yet comprehensive approaches to molecularly characterize hematologic cancers. This chapter encompasses an overview of the test design considerations, molecular diagnostic techniques, and rational application of these tests to non-Hodgkin lymphoma and myeloid malignancies in modern hematopathology practice. The field of benign hematology is also greatly expanding with the broader use of molecular analysis. Disorders of hemoglobins, erythrocytosis, and hemolysis have underlying constitutional genetic abnormalities enabling the diagnostic application of molecular testing in an increasingly sophisticated manner. These advances will also be summarized in this chapter.",
keywords = "Cytogenetics, FISH, Minimal residual disease, Molecular basis of red cell diseases, Molecular diagnosis of lymphoma and myeloid neoplasms, Molecular laboratory techniques, Next-generation sequencing, PCR, Real-time PCR, Sequencing, Translocations",
author = "Rong He and Jennifer Oliveira and James Hoyer and Viswanatha, {David S.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/B978-0-323-47913-4.00024-0",
language = "English (US)",
isbn = "9780323479134",
pages = "712--760.e18",
booktitle = "Hematopathology",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Molecular Hematopathology

AU - He, Rong

AU - Oliveira, Jennifer

AU - Hoyer, James

AU - Viswanatha, David S.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Molecular and cytogenetic analysis is a critical component of hematopathology practice. Correct diagnostic classification, prognosis and therapeutic decisions are often predicated on the presence or absence of tumor-specific genetic abnormalities. Understanding the wide range of abnormalities associated with hematologic neoplasia and interpreting a large number of molecular diagnostic techniques can pose challenges for hematopathologists. From chromosome translocations to complex RNA or DNA mutation patterns, the application of molecular diagnosis has greatly enriched our definitions of lymphoid and myeloid neoplasms. The incessant pace of new technological advances such as next-generation sequencing, as well as medical and scientific knowledge accumulation, requires the continuous updating of our knowledge to make judicious decisions regarding cost-effective yet comprehensive approaches to molecularly characterize hematologic cancers. This chapter encompasses an overview of the test design considerations, molecular diagnostic techniques, and rational application of these tests to non-Hodgkin lymphoma and myeloid malignancies in modern hematopathology practice. The field of benign hematology is also greatly expanding with the broader use of molecular analysis. Disorders of hemoglobins, erythrocytosis, and hemolysis have underlying constitutional genetic abnormalities enabling the diagnostic application of molecular testing in an increasingly sophisticated manner. These advances will also be summarized in this chapter.

AB - Molecular and cytogenetic analysis is a critical component of hematopathology practice. Correct diagnostic classification, prognosis and therapeutic decisions are often predicated on the presence or absence of tumor-specific genetic abnormalities. Understanding the wide range of abnormalities associated with hematologic neoplasia and interpreting a large number of molecular diagnostic techniques can pose challenges for hematopathologists. From chromosome translocations to complex RNA or DNA mutation patterns, the application of molecular diagnosis has greatly enriched our definitions of lymphoid and myeloid neoplasms. The incessant pace of new technological advances such as next-generation sequencing, as well as medical and scientific knowledge accumulation, requires the continuous updating of our knowledge to make judicious decisions regarding cost-effective yet comprehensive approaches to molecularly characterize hematologic cancers. This chapter encompasses an overview of the test design considerations, molecular diagnostic techniques, and rational application of these tests to non-Hodgkin lymphoma and myeloid malignancies in modern hematopathology practice. The field of benign hematology is also greatly expanding with the broader use of molecular analysis. Disorders of hemoglobins, erythrocytosis, and hemolysis have underlying constitutional genetic abnormalities enabling the diagnostic application of molecular testing in an increasingly sophisticated manner. These advances will also be summarized in this chapter.

KW - Cytogenetics

KW - FISH

KW - Minimal residual disease

KW - Molecular basis of red cell diseases

KW - Molecular diagnosis of lymphoma and myeloid neoplasms

KW - Molecular laboratory techniques

KW - Next-generation sequencing

KW - PCR

KW - Real-time PCR

KW - Sequencing

KW - Translocations

UR - http://www.scopus.com/inward/record.url?scp=85054430931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054430931&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-47913-4.00024-0

DO - 10.1016/B978-0-323-47913-4.00024-0

M3 - Chapter

AN - SCOPUS:85054430931

SN - 9780323479134

SP - 712-760.e18

BT - Hematopathology

PB - Elsevier Inc.

ER -